Recent advances in our understanding of how the immune system
interacts with and fights cancer have revolutionized cancer research
The power of genomics in Immuno-Oncology is just starting to be comprehended and applied to this dynamic space. Immune cell repertoire sequencing, RNA-Seq and expression analysis of the tumor microenvironment, and the detection and prediction of immune stimulatory neoantigens are all examples of how genomics can help to answer many of the unknown questions that still exist.
Please join us for a unique opportunity where we will bring together speakers from across the academic, clinical, and biotechnology spectrum to discuss how they are using next-generation sequencing in this exciting space. Whether you are interested in advancing your research, bringing game-changing therapies to market, or partnering to maximize the effectiveness of translational studies, this event aims to provide the research community with insights and ideas to further our understanding of how the immune system can be optimized to fight cancer.
There is no charge to attend this event. However, registration is required.
Achieve unambiguous HLA typing results using a single assay
On behalf of the Illumina HLA team, we invite you to join us for an engaging 3-day, hands-on workshop to explore how next-generation sequencing (NGS) is delivering accuracy and efficiency to HLA typing. Discover why the TruSight® HLA Sequencing Panel has the potential to become a new paradigm in HLA typing.
During this this free educational workshop you will have the opportunity to network with your peers and learn about Illumina’s ultra-high resolution DNA-to-report solution, with the TruSight® HLA Sequencing Panel. The workshop also includes presentations on automating the NGS workflow, and ASHI accreditation submission.
Ground transportation and meals will be provided.
New in 2017
We will be offering an optional introductory session on NGS. The Basics of NGS seminar is designed to help laboratory scientists gain proficiency in the essential aspects of NGS. The seminar will cover TruSight® HLA library preparation, cluster generation, advances in sequencing technology, Illumina sequencing chemistry and systems, and feature live demos of Illumina benchtop sequencing systems. If you are interested in attending this session please select the NGS 101 program during registration. Participants will receive additional continuing education credits for attending.
This is an official continuing education program approved by the American Board of Histocompatibility and Immunogenetics (ABHI). Attendees are eligible to receive 2.85 ABHI continuing education credit (CEC). There is no charge to attend this event but registration is required
Register now as space is limited.